The Texas Children’s Hospital (TCH) and Baylor College of Medicine (BCM) announced that Corbevax, a protein subunit Covid vaccine, has received approval from the Drugs Controller General of India (DCGI) to launch it in India. The initial construct and production process of the vaccine antigen was developed at TCH’s Centre for Vaccine Development.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
As Corbevax has been granted emergency use authorisation in India, Professor Peter Hotez said, “given the urgency, Corbevax will be helpful not only for India but globally as most of the African continent, neighbouring countries around India remain largely unvaccinated.” Emergency use authorisation of Corbevax in India for adults 18 and older will have a great pediatric profile because parents have been giving the same technology (as in vaccine) to their kids for decades.
Important takeaways for all competitive exams:
National News Padma Awards 2026 Honor India’s Distinguished Achievers President Droupadi Murmu conferred 65 Padma…
United Nations Secretary-General António Guterres has issued the strong warning about the growing dangers of…
The State government of Rajasthan has constituted a five-member committee to prepare a draft law…
India's first Made In India C295 transport aircraft is set to be delivered to the…
On 23rd to 24th June, 2026 in Bengaluru India hosting the BRICS Heads of Space…
India has secured the 13th position in the QS World Future Skills Index of 2027…